SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-011954
Filing Date
2023-07-18
Accepted
2023-07-18 16:21:18
Documents
14
Period of Report
2023-07-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krbp-20230717x8k.htm   iXBRL 8-K 36835
2 EX-3.1 krbp-20230717xex3d1.htm EX-3.1 4815
  Complete submission text file 0001558370-23-011954.txt   258252

Data Files

Seq Description Document Type Size
3 EX-101.SCH krbp-20230717.xsd EX-101.SCH 3247
4 EX-101.LAB krbp-20230717_lab.xml EX-101.LAB 632
5 EX-101.PRE krbp-20230717_pre.xml EX-101.PRE 11272
8 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20230717x8k_htm.xml XML 5215
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 231094490
SIC: 2836 Biological Products, (No Diagnostic Substances)